Procaps Group and Genomma Lab Internacional, S.A.B. de C.V., the leading pharmaceutical and personal care company in Latin America, announced a strategic agreement to develop, manufacture and market five Softgel products within Latin America. Through the partnership, Procaps will manufacture and Genomma will market and distribute the products.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PROC:
